Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
187 participants
INTERVENTIONAL
2015-12-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Sugar Sweetened and Diet Beverages Consumed as Part of a Weight-Maintenance Diet on Fat Storage
NCT02252952
Cephalic Phase Responses to Nutritive and Non-Nutritive Sweeteners
NCT06387316
Effects of Low Calorie Sweeteners on Dietary Intakes, Hunger, Appetite and Satiety
NCT02297880
Role of Sweetness in Glucose Regulation
NCT03844230
Absorption and Metabolic Profiles of a Sugar-based Beverage
NCT02226250
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sucrose Sweetened Beverage
100-140 g sucrose/day
Beverage
Participants will receive 1.25 - 1.75 L of sweetened beverage a day for 12 weeks
Aspartame Sweetened Beverage
0.541-0.757 g aspartame Sweetened Beverage/day
Beverage
Participants will receive 1.25 - 1.75 L of sweetened beverage a day for 12 weeks
Saccharin Sweetened Beverage
0.300-0.455 g saccharin Sweetened Beverage/day
Beverage
Participants will receive 1.25 - 1.75 L of sweetened beverage a day for 12 weeks
Sucralose Sweetened Beverage
0.167-0.233 g sucralose Sweetened Beverage/day
Beverage
Participants will receive 1.25 - 1.75 L of sweetened beverage a day for 12 weeks
Rebaudioside A Sweeteened Beverage
0.250-0.350 g rebaudioside A Sweetened Beverage/day
Beverage
Participants will receive 1.25 - 1.75 L of sweetened beverage a day for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beverage
Participants will receive 1.25 - 1.75 L of sweetened beverage a day for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non or rare users of LCS
* Willing to consume large volumes of beverages daily
Exclusion Criteria
* Plan to initiate a new diet plan in the next 6 months
* Exhibit eating restraint
* Pregnant/lactating
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Purdue University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard Mattes
Distinguished Professor of Nutrition Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard D Mattes, PhD
Role: PRINCIPAL_INVESTIGATOR
Purdue University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Purdue University
West Lafayette, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Higgins KA, Mattes RD. A randomized controlled trial contrasting the effects of 4 low-calorie sweeteners and sucrose on body weight in adults with overweight or obesity. Am J Clin Nutr. 2019 May 1;109(5):1288-1301. doi: 10.1093/ajcn/nqy381.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
055-044
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.